Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $25.64B
Liabilities Breakdown FY2025
Total Liabilities: $6.98B
Asset Breakdown
Total Assets: $25.64B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.08B | 19.8% |
| Accounts Receivable | $2.05B | 8.0% |
| Inventory | $1.69B | 6.6% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $1.09B | 4.2% |
| Intangible Assets | $424.2M | 1.7% |
| Other Assets | $15.31B | 59.7% |
Liabilities Breakdown
Total Liabilities: $6.98B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $461.7M | 6.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.52B | 93.4% |